1. Home
  2. UAA vs DYN Comparison

UAA vs DYN Comparison

Compare UAA & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Under Armour Inc.

UAA

Under Armour Inc.

HOLD

Current Price

$6.17

Market Cap

2.6B

ML Signal

HOLD

DYN

Dyne Therapeutics Inc.

HOLD

Current Price

$18.34

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UAA
DYN
Founded
1996
1984
Country
United States
United States
Employees
14400
N/A
Industry
Apparel
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
3.1B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
UAA
DYN
Price
$6.17
$18.34
Analyst Decision
Hold
Strong Buy
Analyst Count
16
14
Target Price
$6.48
$37.00
AVG Volume (30 Days)
6.2M
1.7M
Earning Date
05-12-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1.57
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.13
$8.25
52 Week High
$8.15
$25.00

Technical Indicators

Market Signals
Indicator
UAA
DYN
Relative Strength Index (RSI) 47.10 50.39
Support Level $6.03 $16.47
Resistance Level $6.50 $19.65
Average True Range (ATR) 0.27 0.98
MACD 0.00 -0.09
Stochastic Oscillator 14.38 42.88

Price Performance

Historical Comparison
UAA
DYN

About UAA Under Armour Inc.

Under Armour develops, markets, and distributes athletic apparel, footwear, and accessories in North America, Asia-Pacific, Europe, and Latin America. Consumers of its performance-based clothing and shoes include professional and amateur athletes, sponsored college and professional teams, and people with active lifestyles. The company sells merchandise through wholesale partners, company-owned digital channels, and approximately 450 company-owned outlet and full-price stores. The Baltimore-based firm was founded in 1996 and is led by controlling shareholder Kevin Plank.

About DYN Dyne Therapeutics Inc.

Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease being treated, a linker, and an antigen-binding fragment that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.

Share on Social Networks: